Discover key insights from Allogene Therapeutics' Q1 2025 earnings call, including updates on ALPHA3 progress, trial timelines, cash strategies & ...

Data showed a 93.4% overall diagnostic agreement, indicating that the synthesized 12-lead ECG can support diagnosis of arrhythmias in a manner consistent with standard 12-lead ECGs. Data was presented ...

In an era defined by digital transformation, patient-centered care, and consumer convenience, the traditional orthodonti ...

Q1 2025 Management View Laura Niklason, President and CEO, highlighted the commercial launch of Symvess as the company's top ...

This study presents a valuable meta-analysis that highlights low and highly variable breast cancer survival rates across Africa, emphasizing the pressing need for public health in Africa. The evidence ...

Ketamine Lead Gen With 10+ years in mental health marketing, Ketamine Lead Gen sets the standard for patient growth in Ketamine, TMS, MeRT, ...

Germany’s organ transport devices market is poised to exhibit a CAGR of 5.5% between 2025 and 2035. Currently, it holds the highest share in the Western Europe market.” — Sabyasachi Ghosh, Principal ...

Consultant urologist Dr Nick Burns-Cox has been working on his own innovation, the Pee-In-Pot (PiP) for 10 years. Made from ...

According to WHO, India accounted for the highest share of global tuberculosis cases in 2023—26%. However, the country has a ...

State officials are pursuing a new strategy to funnel millions of Medicaid dollars into the city’s public hospital system ...

Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ETCompany ParticipantsDavid Barnard - Investor Relations, ...

In 2025, as per their experts, Dr. Kinnar Shah, the driving force behind the brand of Smile Concepts, continues to shine as a ...